Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0476089 (endometrial cancer)
 11,379 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The University of Michigan endometrial carcinoma cell line UM-EC-1 was derived from a poorly differentiated endometrial adenocarcinoma of a 66-yr-old white female. Cell cultures were started using both tumor explants and a cell suspension obtained from collagenase-treated tumor tissue. The collagenase-derived cell suspension gave rise to monolayer cultures which grew rapidly from the outset. This subline of UM-EC-1 has now been subcultured more than 50 times. Cells derived from the tumor explants grew more slowly initially, but after a lag phase of 5 to 6 wk, this subline also exhibited rapid logarithmic growth and reached the same growth rate as that of the collagenase-treated cells. The explant subline has been subcultured more than 37 times. The doubling time of both sublines is 24 h under optimal growth conditions. The karyotype of both cell cultures is 43, XX, inv(1)(p32q42), -4, +der(8) t(8;12)(p23.1;q22), del(9)(q11), -13, -13, +t(13;13) (p13;p13), del(18)(q), -19, -22, -22, +t(22;22)(p11;p11). The net result of the chromosome losses and rearrangements was monosomy 4, duplication 8p23.1----qter, deletion 9q11----9qter, duplication 12q22----qter, deletion 18q, and monosomy 19. The t(13;13) and the t(22;22) were dicentric by C-banding. Virtually all of the chromosome changes were stable in multiple passages except that there was mosaicism for chromosome 13. Some cells contained a single copy of 13 and others had t(13;13). The available evidence indicates the t(13;13) is an isochromosome. UM-EC-1 cells produced tumors histologically similar to the original tumor in male, female, and ovariectomized female athymic mice. UM-EC-1 cells express human class I histocompatibility antigens as assessed by binding of antibodies to nonpolymorphic HLA and beta-2-microglobulin antigens. Blood group antigens A and H were absent although the patient is blood type A and these antigens are normally expressed in endometrial glands. A rearrangement involving the region of chromosome nine that carries the ABH locus may be related to the absence of blood group antigen expression by these cells. The E7 membrane antigen, the locus for which resides on the short arm of chromosome 11, was expressed strongly which is consistent with the presence of two intact copies of chromosome 11 in these cells.
 ...
PMID:UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. 334 65

Adipose tissue is the principal site of extraglandular estrogen formation in nonpregnant women. The importance of adipose tissue as a site of estrogen formation is emphasized by the finding that increased body weight is associated with an increased incidence of endometrial carcinoma. In the present study, the kinetics of estrogen formation from androstenedione by adipocytes and by stromal cells isolated from human adipose tissue as well as by membrane fractions prepared from these cells were investigated. Subcutaneous adipose tissue samples obtained from women were dispersed by collagenase treatment, and aromatase activity was assayed by the incorporation of tritium from [1-3H]androstenedione into [3H]water. As previously reported, aromatase activity was found in intact stromal cells of adipose tissue, whereas little aromatase activity was detected in intact adipocytes. When crude membrane fractions (100,000 X g pellet) of stromal cells and adipocytes were incubated in the presence of [1-3H]androstenedione and an NADPH-generating system, however, aromatase activity was found in membrane fractions of both stromal cells and adipocytes, and estrogen formation increased in a linear manner as a function of time and membrane protein concentration. The apparent Michaelis constant (Km) of aromatase for androstenedione of intact stromal cells was 0.03 microM, whereas intact adipocytes did not convert androstenedione to estrone at substrate concentrations up to 3.0 microM. In membrane fractions of stromal cells, the rate of aromatization as a function of androstenedione concentration did not follow simple Michaelis-Menten kinetics, and both low affinity (Km = 1.03 microM) and high affinity (Km = 0.10 microM) components were observed. The affinity of androstenedione for aromatase of adipocyte membrane fractions was low; the rate of aromatization was not saturable at concentrations of androstenedione up to 3.0 microM. When intact adipocytes were incubated with [1-3H]androstenedione, then homogenized, and the homogenate was treated by differential centrifugation, the radioactivity that was added to the medium was found almost entirely in the lipid fraction of the cells. This finding is indicative that the low aromatase activity in intact adipocytes is the result of sequestration of steroid in lipid droplets in the cells. We suggest that the stromal cells of adipose tissue are a major source of the increased estrogen production in obese persons; a role for adipocytes in the regulation of adipose tissue estrogen formation, however, cannot be excluded at this time.
 ...
PMID:Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes. 664 29

To elucidate potential mechanisms involved in the increased incidence of endometrial carcinomas in tamoxifen-treated patients, we examined the in-vitro effects of tamoxifen on endometrial cancer cells. The effects of tamoxifen, alone and in combination with oestradiol, on cell proliferation, plasminogen activator (PA) activity, glycogen synthase and phosphorylase activities, p53 protein concentration, and collagenase expression were assessed in two human adenocarcinoma cell lines. These lines were the oestrogen receptor-positive (Ishikawa) cells, representing a well-differentiated endometrial adenocarcinoma, and oestrogen receptor-negative (HEC-1A) cells, derived from a poorly differentiated endometrial adenocarcinoma. Tamoxifen or oestradiol alone and their combination significantly enhanced cellular proliferation of Ishikawa but not of HEC-1A cells. Both lines produced appreciable PA activity, most of which was of the urokinase type. Tamoxifen and oestradiol stimulated this activity in Ishikawa cells but not in HEC-1A cells. The effect of oestradiol was dose-dependent in a linear fashion, while tamoxifen produced a stimulation peaking at 10(-8) M and declining at higher concentrations. Tamoxifen in combination with oestradiol exhibited a synergistic effect on proliferation and on PA activity. The response of PA extended beyond the increase in proliferation, leading to higher specific activity of PA in the tamoxifen-treated cultures. In Ishikawa cells, oestradiol also increased glycogen synthase and glycogen phosphorylase activities, while tamoxifen markedly suppressed these enzymes. Oestradiol, tamoxifen, and their combination had no apparent effect on the expression of protein p53 in Ishikawa cells, or on gelatinase activity in either Ishikawa or HEC-1A cells. The present findings imply that tamoxifen produces oestrogen-agonistic effects on cell proliferation and PA activity, and oestrogen antagonistic effects on glycogen synthase and glycogen phosphorylase activities, but fails to regulate p53 and gelatinase expression. The tamoxifen-responsive systems were only observed in oestrogen-responsive adenocarcinoma cells. Thus, only certain potential oncogenic effects of tamoxifen can be simulated in vitro, and when present, these effects are enhanced in the presence of oestradiol.
 ...
PMID:Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells. 946 46